Inhibitory efficacy of cycloSal-nucleoside monophosphates of aciclovir and brivudin on DNA synthesis of orthopoxvirusesSAUERBREI, Andreas; MEIER, Chris; MEERBACH, Astrid et al.Antiviral chemistry & chemotherapy. 2006, Vol 17, Num 1, pp 25-31, issn 0956-3202, 7 p.Article

Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgiaWASSILEW, Sawko W; WUTZLER, Peter; WUTZLER, Peter et al.WUTZLER, Peter; WUTZLER, Peter et al.Antiviral research. 2003, Vol 59, Num 1, pp 57-60, issn 0166-3542, 4 p.Article

Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered studyWASSILEW, Sawko W; WUTZLER, Peter.Antiviral research. 2003, Vol 59, Num 1, pp 49-56, issn 0166-3542, 8 p.Article

Brivudin als alternative systemische Therapie zu Aciclovir und Ganciclovir bei akutem retinalen Nekrosesyndrom durch Varizella-Zoster-Virus = Brivudine as an alternative systemic therapy to aciclovir and ganciclovir in acute retinal necrosis syndrome due to varicella-zoster virusVIJ, Oliver; BORNFELD, Norbert; ROGGENDORF, Michael et al.Klinische Monatsblätter für Augenheilkunde. 2003, Vol 220, Num 10, pp 710-715, issn 0023-2165, 6 p.Article

Acute hepatitis due to brivudin: A case reportMOTTU, Alexandre; RUBBIA-BRANDT, Laura; BIHL, Florian et al.Journal of hepatology. 2009, Vol 51, Num 5, pp 967-969, issn 0168-8278, 3 p.Article

Actualización en el tratamiento del herpes zóster = Update in the treatment of herpes zosterESPANA, Agustin; REDONDO, Pedro.Actas dermo-sifiliográficas (Ed. impresa). 2006, Vol 97, Num 2, pp 103-114, issn 0001-7310, 12 p.Article

Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudinANDREI, Graciela; BALZARINI, Jan; FITEN, Pierre et al.Journal of virology. 2005, Vol 79, Num 9, pp 5863-5869, issn 0022-538X, 7 p.Article

The role of antivirals in the management of neuropathic pain in the older patient with herpes zosterLILIE, H. Martina; WASSILEW, Sawko W.Drugs & aging. 2003, Vol 20, Num 8, pp 561-570, issn 1170-229X, 10 p.Article

Novel mouse models for the investigation of experimental drugs with activity against human varicella-zoster virusWEBER, O.Antiviral chemistry & chemotherapy. 2000, Vol 11, Num 4, pp 283-290, issn 0956-3202Article

Disseminated cutaneous herpes zoster complicated by acyclovir nephrotoxicity and successfully treated with brivudinAKSOY, Berna; ALTAYKAN-HAPA, Asli; CENGIZ, Abdülkadir et al.EJD. European journal of dermatology. 2010, Vol 20, Num 2, pp 247-248, issn 1167-1122, 2 p.Article

Human and viral nucleoside/nucleotide kinases involved in antiviral drug activation: Structural and catalytic propertiesDEVILLE-BONNE, Dominique; EL AMRI, Chahrazade; MEYER, Philippe et al.Antiviral research. 2010, Vol 86, Num 1, pp 101-120, issn 0166-3542, 20 p.Article

Linear darier disease with herpes zoster superinfection treated successfully by brivudineABRAHAM, S; JONES, A; TOUTOUS-TRELLU, L et al.British journal of dermatology (1951). 2006, Vol 154, Num 2, pp 365-367, issn 0007-0963, 3 p.Article

Cellular and human pharmacokinetics of brivudin, a new antiherpetic drugCREA, A. E. G; LAFRATE, E. M; EVANGELISTA, S et al.Recent research developments in drug metabolism and disposition Vol. 2 - 2004. Recent developments in drug metabolism and disposition. 2004, pp 27-37, isbn 81-7895-135-5, 11 p.Book Chapter

Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV)DEGREVE, B; DE CLERCQ, E; BALZARINI, J et al.Gene therapy (Basingstoke). 2000, Vol 7, Num 18, pp 1543-1552, issn 0969-7128Article

Development and validation of a bioanalytical assay for (E)-5-(2-bromovinyl)-2'-deoxyuridin in plasma by capillary zone electrophoresisREEUWIJK, H. J. E. M; TJADEN, U. R; VAN DER GREEF, J et al.Journal of chromatography. B, Biomedical sciences and applications. 1999, Vol 726, Num 1-2, pp 269-276, issn 1387-2273Article

Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnetBLEYMEHL, Karoline; CINATL, Jindrich; SCHMIDT-CHANASIT, Jonas et al.Medical microbiology and immunology. 2011, Vol 200, Num 3, pp 193-202, issn 0300-8584, 10 p.Article

RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patientsHEINRICH, Jorg-Christian; TUUKKANEN, Anne; SCHROEDER, Michael et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 9, pp 1349-1361, issn 0171-5216, 13 p.Article

Antimicrobial Strategies : Inhibition of Viral Polymerases by 3'-Hydroxyl NucleosidesDEVAL, Jerome.Drugs (Basel). 2009, Vol 69, Num 2, pp 151-166, issn 0012-6667, 16 p.Article

Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes virusesMEERBACH, Astrid; MEIER, Chris; SAUERBREI, Andreas et al.International journal of antimicrobial agents (Print). 2006, Vol 27, Num 5, pp 423-430, issn 0924-8579, 8 p.Article

Prophylaxe und Therapie von Varicella-zoster-Virus-Infektionen bei immunsupprimierten Kindern = Prophylaxis and therapy for varicella Zoster virus infections in immunsuppressed childrenRÖSSIG, C; RITTER, J; JÜRGENS, H et al.Monatsschrift für Kinderheilkunde. 1998, Vol 146, Num 3, pp 200-207, issn 0026-9298Conference Paper

Mechanism of antiviral action of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) : direct evidence with [¹⁴C]BVDU in herpes simplex virus-infected cellsCIUCCI, A; LAFRATE, E. M; MANZINI, S et al.Antiviral chemistry & chemotherapy. 1997, Vol 8, Num 6, pp 565-571, issn 0956-3202Article